U.S., May 22 -- ClinicalTrials.gov registry received information related to the study (NCT06983704) titled 'Assessing Combined Bevacizumab-Mitomycin C Use During Ahmed Valve Revision in Recurrent Pediatric Glaucoma' on May 14.
Brief Summary: To asess the efficacy and safety of combining subconjunctival bevacizumab with mitomycin C (MMC) during AGV revision surgery in pediatric patients with recurrent glaucoma.
Study Start Date: Feb. 09, 2024
Study Type: INTERVENTIONAL
Condition:
Pediatric Glaucoma
Intervention:
PROCEDURE: AGV plate
AGV plate using a 27-gauge needle
PROCEDURE: bevacizumab injection
subconjunctival injection of bevacizumab
Recruitment Status: COMPLETED
Sponsor: Benha University
Information provided by (Responsibl...